EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)

MLA

A. Horne, et al. “EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-Small Cell Lung Cancer (NSCLC).” Journal of Thoracic Oncology, vol. 17, Sept. 2022, pp. S267–68. EBSCOhost, https://doi.org/10.1016/j.jtho.2022.07.453.

APA

A. Horne, S. Brown, K. Butterworth, A. Chalmers, F. Collinson, C. Dive, C. Faivre-Finn, M. Forster, K. Franks, A. Gilbert, M. Hallam, G. Hanna, S. Harrow, J. Hartley, C. Hiley, R. Jones, E. Katona, J. Kendall, M. Krebs, … A. Greystoke. (2022). EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 17, S267–S268. https://doi.org/10.1016/j.jtho.2022.07.453

Chicago

A. Horne, S. Brown, K. Butterworth, A. Chalmers, F. Collinson, C. Dive, C. Faivre-Finn, et al. 2022. “EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-Small Cell Lung Cancer (NSCLC).” Journal of Thoracic Oncology 17 (September): S267–68. doi:10.1016/j.jtho.2022.07.453.